Fetal adverse drug reactions with biologic Disease Modifying Anti-Rheumatic Drugs used during pregnancy: Insights from a World Health Organization pharmacovigilance database study (VigiBase (R))

Abstract

International audienc

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Last time updated on 21/08/2022